TBPH Theravance Biopharma, Inc.
2026Q1 · CUSIP G8807B106 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
170
Δ holders QoQ
+2
Breadth percentile
Top 53%
Whale holders
99
Δ whales
+7
Inst. holding value
$806M
New positions
40
Closed positions
38
Price momentum (1Q)
—
Put / Call
4/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 3 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 12% | — | — |
| 2022Q3 | Top 13% | — | — |
| 2020Q2 | Top 17% | — | — |
Options Sentiment
Put holders
4
QoQ: +4
Call holders
3
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
7.7
EPS (TTM)
$2.20
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+68.2%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)